“Revolutionizing Cancer Treatment: The Role of Starch‐Based Nanoparticles in Targeted Therapy” DOI Open Access
Devesh U. Kapoor,

Geeta Patel,

Bhupendra G. Prajapati

и другие.

Starch - Stärke, Год журнала: 2025, Номер unknown

Опубликована: Фев. 10, 2025

ABSTRACT The biocompatible and biodegradable polysaccharide starch is a great platform for the development of nanoparticles (NPs). Due to its special qualities, which include high stability, low toxicity, ease modification, it desirable option administration anticancer drugs. Targeted cancer therapy has found potential carrier in starch‐based (SNPs). SNPs can be functionalized with ligands target cells particular. These allow targeted medication delivery by identifying overexpressed receptors on tumor surfaces. have been studied relation chemotherapeutics, siRNAs, photothermal treatments, among other agents. They are also used combination therapy, where their combined targeting improves treatment outcomes. being evaluated number clinical trials. trials evaluate patient outcomes, safety, efficacy offer important information future uses. Regulatory bodies closely monitor various treatments based NPs. Clinical translation requires an understanding safety profiles, biodistribution, clearance mechanisms. In this review, we examine enhance through drug targeting.

Язык: Английский

QbD- Driven Development and Characterization of Lactoferrin-Loaded Nanoparticles in In-Situ Gel for Treating Postmenopausal Osteoporosis DOI
Priya Patel,

Aishwarya Trivedi,

Bhupendra G. Prajapati

и другие.

Next research., Год журнала: 2025, Номер unknown, С. 100142 - 100142

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0
“Revolutionizing Cancer Treatment: The Role of Starch‐Based Nanoparticles in Targeted Therapy” DOI Open Access
Devesh U. Kapoor,

Geeta Patel,

Bhupendra G. Prajapati

и другие.

Starch - Stärke, Год журнала: 2025, Номер unknown

Опубликована: Фев. 10, 2025

ABSTRACT The biocompatible and biodegradable polysaccharide starch is a great platform for the development of nanoparticles (NPs). Due to its special qualities, which include high stability, low toxicity, ease modification, it desirable option administration anticancer drugs. Targeted cancer therapy has found potential carrier in starch‐based (SNPs). SNPs can be functionalized with ligands target cells particular. These allow targeted medication delivery by identifying overexpressed receptors on tumor surfaces. have been studied relation chemotherapeutics, siRNAs, photothermal treatments, among other agents. They are also used combination therapy, where their combined targeting improves treatment outcomes. being evaluated number clinical trials. trials evaluate patient outcomes, safety, efficacy offer important information future uses. Regulatory bodies closely monitor various treatments based NPs. Clinical translation requires an understanding safety profiles, biodistribution, clearance mechanisms. In this review, we examine enhance through drug targeting.

Язык: Английский

Процитировано

0